Skip to content
TrialScanner

NCT06208124

A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors

Phase 1/Phase 2CompletedIMRXLead

Registry record

Lead sponsor
Immuneering Corporation
Conditions
Advanced Solid Tumor (Phase 1); Pancreas Adenocarcinoma; Non-small Cell Lung Cancer; Malignant Melanoma (Cutaneous)
Primary completion
Apr 30, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06208124 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06208124: A Study of IMM-6-415 in... | TrialScanner